| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EVMN | Evommune, Inc. | Kyle Carver | Chief Financial Officer | Jul 08, 2026 | Buy | $13.26 | 1,000 | 13,260 | 60,335 | Jul 10, 2026, 07:59 PM | |
| EVMN | Evommune, Inc. | Kyle Carver | Chief Financial Officer | May 28, 2026 | Option/RSU Exercise | $2.99 | 15,000 | 44,850 | 77,510 | Jun 01, 2026, 07:59 PM | |
| EVMN | Evommune, Inc. | Kyle Carver | Chief Financial Officer | May 28, 2026 | Sale | $22.84 | 18,175 | 415,117 | 59,335 | Jun 01, 2026, 07:59 PM | |
| EVMN | Evommune, Inc. | Kyle Carver | Chief Financial Officer | Dec 09, 2025 | Tax Payment (Shares) | $17.84 | 13,290 | 237,094 | 62,510 | Dec 11, 2025, 04:20 PM | |
| EVMN | Evommune, Inc. | Kyle Carver | Chief Financial Officer | Nov 07, 2025 | Conversion | - | 3,175 | - | 75,800 | Nov 12, 2025, 04:16 PM |
- Subscribe
- Premium
- C-Suite
- Insiders
- M&A
- Gurus
- Spinoffs
- Buybacks
- More